Interaction of the two disease processes, particularly due to the upregulation of IL-6 and IL-7 in both conditions, has the potential to produce serious adverse outcomes, as described in two case studies with GCA-associated visual loss (28, 29). This evidence concerns the gene IL6 and temporal arteritis.